Literature DB >> 6833758

Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.

B Perussia, S Starr, S Abraham, V Fanning, G Trinchieri.   

Abstract

We describe the production of the monoclonal antibody B73.1, reacting with a subset of human lymphocytes and, in about one-half of the donors, with neutrophilic polymorphonuclear leukocytes. In the peripheral blood from normal adult donors, 14.6 +/- 8.5% of the lymphocytes react with B73.1 antibody. The B73.1(+) lymphocyte subset does not bear markers of typical T or B cells and corresponds to the lymphocyte subset containing antibody-dependent killer (K) and natural killer (NK) cells. We demonstrate that: a) virtually all lymphocytes with K/NK cytotoxic activity are found in the lymphocyte subpopulation bearing the B73.1-defined antigen; b) the B73.1(+) lymphocyte subset bears the combination of antigens known to be present on K/NK cells; and c) there is a positive correlation between the level of cytotoxicity and the actual number of B73.1(+) lymphocytes in individual donors. We also report the distribution of B73.1(+) lymphocytes according to donor age and tissue types. The use of the B73.1 antibody in quantitating the actual number of K/NK cells and in performing functional studies on spontaneous cytotoxicity is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6833758

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  137 in total

1.  On the cell biology of pit cells, the liver-specific NK cells.

Authors:  Dian-Zhong Luo; David Vermijlen; Bulent Ahishali; Vasilis Triantis; Georgia Plakoutsi; Filip Braet; Karin Vanderkerken; Eddie Wisse
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease.

Authors:  J Wu; J C Edberg; P B Redecha; V Bansal; P M Guyre; K Coleman; J E Salmon; R P Kimberly
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

3.  Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity.

Authors:  O Mandelboim; P Malik; D M Davis; C H Jo; J E Boyson; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

4.  Identification of multiple isoforms of the low-affinity human IgG Fc receptor.

Authors:  T Seki
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

5.  A human immunoglobulin G receptor exists in both polypeptide-anchored and phosphatidylinositol-glycan-anchored forms.

Authors:  B J Scallon; E Scigliano; V H Freedman; M C Miedel; Y C Pan; J C Unkeless; J P Kochan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

6.  Interleukin 2 enhances natural killing of varicella-zoster virus-infected targets.

Authors:  M Ito; S Bandyopadhyay; M Matsumoto-Kobayashi; S C Clark; D Miller; S E Starr
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

7.  Coexpression of Fc gamma receptor IIIA and interleukin-2 receptor beta chain by a subset of human CD3+/CD8+/CD11b+ lymphocytes.

Authors:  S Zupo; L Azzoni; R Massara; A D'Amato; B Perussia; M Ferrarini
Journal:  J Clin Immunol       Date:  1993-05       Impact factor: 8.317

8.  The relationship of HNK-1 (Leu 7) and VEP13 antigens on human cells mediating natural killing.

Authors:  H Rumpold; D Kraft; G Gastl; C Huber
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

9.  Noninhibitory binding of human interleukin-2-activated natural killer cells to the germ tube forms of Candida albicans.

Authors:  G Arancia; A Molinari; P Crateri; A Stringaro; C Ramoni; M L Dupuis; M J Gomez; A Torosantucci; A Cassone
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

10.  Involvement of cell surface macromolecules sensitive to alkylating ketones in lysis by human peripheral blood NK cells.

Authors:  M M Dawson; U Shipton; M Moore
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.